A pharmacogene database enhanced by the 1000 Genomes Project
- 1 October 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 19 (10), 829-832
- https://doi.org/10.1097/fpc.0b013e3283317bac
Abstract
Human genetic variation is likely to be responsible for a substantial fraction of the variability in complex traits including drug response. Single nucleotide polymorphisms have been implicated in drug response using genome-wide association studies as well as candidate–gene approaches. A more comprehensive catalogue of human genetic variation should complement the current large-scale genotypic dataset from the International HapMap Project, which focuses on common genetic variants. The 1000 Genomes Project is an international research effort that aims to provide the most comprehensive map of human genetic variation using next-generation sequencing platforms. Owing to the lack of convenient tools, however, it is a challenge for the pharmacogenetic research community to take advantage of these data. Here, we present a new database of some pharmacogenes of particular interest to pharmacogenetic researchers. Our database provides a convenient portal for immediate utilization of the newly released 1000 Genomes Project data in pharmacogenetic studies.Keywords
This publication has 14 references indexed in Scilit:
- 1000 Genomes Project Promises Closer Look at Variation in Human GenomePublished by American Medical Association (AMA) ,2008
- Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing ProjectsCurrent Bioinformatics, 2008
- Single-Molecule DNA Sequencing of a Viral GenomeScience, 2008
- The impact of next-generation sequencing technology on geneticsTrends in Genetics, 2008
- Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent Toxicity2008
- The HapMap Resource is Providing New Insights into Ourselves and its Application to PharmacogenomicsBioinformatics and Biology Insights, 2008
- Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancerOncology Reports, 2007
- A haplotype map of the human genomeNature, 2005
- Detection of large-scale variation in the human genomeNature Genetics, 2004
- Current and future potential roles of the platinum drugs in the treatment of ovarian cancerAnnals of Oncology, 2001